Featured Research

from universities, journals, and other organizations

Benefits From Alzheimer's Plaque-Producing Reaction? Science Study Proposes Role In Gene Expression

Date:
July 9, 2001
Source:
American Association For The Advancement Of Science
Summary:
The molecule that spawns "plaque" buildup in the brains of Alzheimer's patients may also play a role in normal gene expression, suggests a study using cultured cells. The study will be published in the 6 July issue of the international journal, Science.

The molecule that spawns "plaque" buildup in the brains of Alzheimer's patients may also play a role in normal gene expression, suggests a study using cultured cells. The study will be published in the 6 July issue of the international journal, Science.

If these findings prove true in humans, they may help scientists understand why the plaques form and perhaps even the basic mechanisms that lead to the disease.

The study also raises the possibility of unwanted side effects from drugs intended to prevent plaque formation, by revealing a biological use for the reaction that produces the plaque molecules. Such drugs are currently under investigation as possible Alzheimer's therapies.

Researchers have long wondered about the normal function of the parent protein to the plaque molecules--the "amyloid precursor protein," or "APP," which is embedded in the cell membranes of neurons in the brain.

The protein is split into pieces by a series of enzymes. The last of these reactions, called "gamma cleavage," cuts the remaining molecule into two smaller pieces.

The infamous Alzheimer's plaques form from one of these pieces, the "beta-amyloid" peptide, which is secreted from the cell. The other piece is the APP "tail," which dangles from the membrane into the cell. Its function has thus far been a mystery.

In their Science study, authors Xinwei Cao and Thomas C. Südhof of the University of Texas Southwestern Medical Center and Howard Hughes Medical Institute propose that the APP tail enters the nucleus and participates in gene expression.

"This would, for the first time, provide a biological reason for gamma cleavage, which liberates beta amyloid fragment that causes Alzheimer's disease," said Südhof.

The researchers took their lead from another protein, called "Notch," which is found in the same part of the cell as APP and is cleaved by a related enzyme.

One of the Notch fragments then helps regulate a process called transcription, the copying of DNA into transportable RNA versions, which then direct protein assembly elsewhere in the cell. Südhof and Cao investigated whether the APP tail might do the same.

Transcription requires a complex assortment of molecular machinery to unzip the DNA double helix and assemble a corresponding RNA chain. Certain molecules must bind to the "start" section of the gene's DNA sequence, and help provide a hookup to the rest of the transcription machinery.

The Science authors found that the APP tail did help activate transcription, when it was bound with two other molecules. One, calledTip60, is part of a large complex of other transcription molecules. The other, Fe65 doesn't have a currently known function, but it may be part of the hookup mechanism that actually binds to the DNA, according to Südhof and Cao.

Because they didn't know which gene APP might bind to, the researchers borrowed velcro-like patches called binding domains from two other transcription molecules, known to activate genes that express fluorescent proteins.

Binding domains only provide the physical link to a certain gene; they don't activate transcription by themselves. The researchers fused one of the binding domains to the complex of the APP tail and its two partners, and then inserted the whole structure into a cultured tissue cell. Like a new light switch connected to an existing wiring system, the complex did activate the fluorescing gene.

"Transcription is an orchestra of factors that have to come together. We've shown that the APP tail can provide the hookup to the many other proteins needed for transcription," Südhof said.

One of the next important questions is which gene might be the APP tail's actual target. In the meantime, however, these findings may still shed light on mechanisms behind Alzheimer's, according to Südhof.

"The regulation of transcription would also, as a byproduct, regulate the amount of amyloid-beta produced. I think it is likely that Alzheimer's disease is in general a long term change in this regulation. What I'm hypothesizing is that, if this pathway is turned on more than normal over long periods of time, you'd produce more amyloid-beta;" said Südhof.

If this hypothesis turns out to be true, it would raise questions about the effectiveness of fighting Alzheimer's by preventing the splitting of APP.

"Indeed, if transcriptional regulation initiated by gamma-cleavage is an important function, which we have every reason to believe, gamma-secretase inhibitors may have as yet unexpected side effects, because they interfere with transcriptional regulation," Südhof said.


Story Source:

The above story is based on materials provided by American Association For The Advancement Of Science. Note: Materials may be edited for content and length.


Cite This Page:

American Association For The Advancement Of Science. "Benefits From Alzheimer's Plaque-Producing Reaction? Science Study Proposes Role In Gene Expression." ScienceDaily. ScienceDaily, 9 July 2001. <www.sciencedaily.com/releases/2001/07/010709073434.htm>.
American Association For The Advancement Of Science. (2001, July 9). Benefits From Alzheimer's Plaque-Producing Reaction? Science Study Proposes Role In Gene Expression. ScienceDaily. Retrieved September 17, 2014 from www.sciencedaily.com/releases/2001/07/010709073434.htm
American Association For The Advancement Of Science. "Benefits From Alzheimer's Plaque-Producing Reaction? Science Study Proposes Role In Gene Expression." ScienceDaily. www.sciencedaily.com/releases/2001/07/010709073434.htm (accessed September 17, 2014).

Share This



More Mind & Brain News

Wednesday, September 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

FDA Eyes Skin Shocks Used at Mass. School

FDA Eyes Skin Shocks Used at Mass. School

AP (Sep. 15, 2014) — The FDA is considering whether to ban devices used by the Judge Rotenberg Educational Center in Canton, Massachusetts, the only place in the country known to use electrical skin shocks as aversive conditioning for aggressive patients. (Sept. 15) Video provided by AP
Powered by NewsLook.com
Shocker: Journalists Are Utterly Addicted To Coffee

Shocker: Journalists Are Utterly Addicted To Coffee

Newsy (Sep. 13, 2014) — A U.K. survey found that journalists consumed the most amount of coffee, but that's only the tip of the coffee-related statistics iceberg. Video provided by Newsy
Powered by NewsLook.com
'Magic Mushrooms' Could Help Smokers Quit

'Magic Mushrooms' Could Help Smokers Quit

Newsy (Sep. 11, 2014) — In a small study, researchers found that the majority of long-time smokers quit after taking psilocybin pills and undergoing therapy sessions. Video provided by Newsy
Powered by NewsLook.com
'Fat Shaming' Might Actually Cause Weight Gain

'Fat Shaming' Might Actually Cause Weight Gain

Newsy (Sep. 11, 2014) — A study for University College London suggests obese people who are discriminated against gain more weight than those who are not. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

      Technology News



      Save/Print:
      Share:  

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile iPhone Android Web
      Follow Facebook Twitter Google+
      Subscribe RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins